移植肾动脉狭窄手术后的远期结局
该研究报道法国一家肾移植中心2004至2009年间10例因术后移植肾动脉狭窄且经多学科团队评估不适合血管内操作而接受手术的患者的经验与长期随访。术后无移植物丢失,2例术后第一周需血液透析,平均随访9.8±2.1年,1例因慢性排斥在移植后10.3年丢失移植物,1例需血管内扩张,5年无移植物丢失,所有患者血压得到控制。
要点
- 10例术后移植肾动脉狭窄患者因不适合血管内操作接受手术,平均随访9.8±2.1年。
- 术后无移植物丢失,2例术后第一周需血液透析,5年无移植物丢失。
- 1例因慢性排斥在移植后10.3年丢失移植物,1例需血管内扩张,所有患者血压得到控制。
核心结论
- 移植肾动脉狭窄手术对移植物存活和功能安全有效,对于不适合血管内修复的患者应考虑手术。
研究设计与样本
- 法国一家肾移植中心的经验与长期随访,2004年至2009年间纳入10例术后移植肾动脉狭窄且被多学科团队认为不适合血管内操作而转诊手术的患者。
主要发现
- 从移植到手术的平均时间为139.8±136.4天。
- 临床指征为少尿、无尿或尿量急性减少(n=5)、难治性高血压(n=4)以及同种异体移植物功能持续下降(n=1)。
- 影像学显示的开口部狭窄合并髂外动脉狭窄(n=3)或早期分叉(n=2),以及扭结(n=5)。
- 血运重建技术包括大隐静脉旁路移植(n=5)和髂内动脉吻合(n=5)。
- 术后期间无移植物丢失,但2例在术后第一周需要血液透析;平均随访9.8±2.1年,1例在移植后10.3年因慢性排斥丢失移植物,1例需要血管内扩张;5年时无移植物丢失,所有患者血压得到控制。
临床怎么用
- 作者认为,对于不适合血管内修复的移植肾动脉狭窄患者,应考虑手术治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The occurrence of transplant renal artery stenosis (TRAS) ranges from 1 to 23% and is associated with resistant hypertension, volume overload, graft dysfunction, and poor long-term graft and patient survival. Enhancing graft availability with expanded criteria donors results in the transplantation of kidneys with atherosclerotic arteries, increasing the risk of vascular complications. Although endovascular management is the first-line strategy in this context, in some patients, surgery has to be considered. We report the experience and long-term follow-up of TRAS surgery in a French kidney transplantation center. Between 2004 and 2009, 10 patients with postoperative TRAS, considered unfit for an endovascular procedure by a multidisciplinary team, were addressed for surgery. Mean time from transplantation to surgery was 139.8 ± 136.4 days. Clinical indications were oliguria, anuria, or acute decrease in urine output (n = 5), resistant hypertension (n = 4), and persistence of a decreased allograft function (n = 1). Imaging-revealed ostial stenosis is associated with external iliac artery stenosis (n = 3) or early bifurcation (n = 2), and kinking (n = 5). Revascularization techniques consisted in a great saphenous vein bypass (n = 5) and internal iliac artery anastomosis (n = 5). In the postoperative period, there was no graft loss, but 2 patients required hemodialysis during the first week. Mean follow-up was 9.8 ± 2.1 years. One patient lost his graft 10.3 years after transplantation due to chronic rejection, and 1 patient needed endovascular dilation. There was no graft loss at 5 years. Blood pressure was controlled in all patients. Surgical intervention for TRAS is safe and effective on graft survival and graft function and has to be considered for patients unsuitable for endovascular repair.
引用
- Rouer M, Godier S, Monnot A, et al. Long-term Outcomes after Transplant Renal Artery Stenosis Surgery. Ann Vasc Surg. 2018. PMID: 30092435. doi:10.1016/j.avsg.2018.05.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。